SLFN5-mediated chromatin dynamics sculpt higher-order DNA repair topology.

53BP1 DNA double-strand break repair PARP inhibitor sensitivity SLFN5 chromatin mobility chromatin topology class switch recombination non-homologous end joining super-resolution microscopy telomere fusions

Journal

Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571

Informations de publication

Date de publication:
06 04 2023
Historique:
received: 17 05 2022
revised: 23 12 2022
accepted: 01 02 2023
pmc-release: 06 04 2024
medline: 11 4 2023
pubmed: 1 3 2023
entrez: 28 2 2023
Statut: ppublish

Résumé

Repair of DNA double-strand breaks (DSBs) elicits three-dimensional (3D) chromatin topological changes. A recent finding reveals that 53BP1 assembles into a 3D chromatin topology pattern around DSBs. How this formation of a higher-order structure is configured and regulated remains enigmatic. Here, we report that SLFN5 is a critical factor for 53BP1 topological arrangement at DSBs. Using super-resolution imaging, we find that SLFN5 binds to 53BP1 chromatin domains to assemble a higher-order microdomain architecture by driving damaged chromatin dynamics at both DSBs and deprotected telomeres. Mechanistically, we propose that 53BP1 topology is shaped by two processes: (1) chromatin mobility driven by the SLFN5-LINC-microtubule axis and (2) the assembly of 53BP1 oligomers mediated by SLFN5. In mammals, SLFN5 deficiency disrupts the DSB repair topology and impairs non-homologous end joining, telomere fusions, class switch recombination, and sensitivity to poly (ADP-ribose) polymerase inhibitor. We establish a molecular mechanism that shapes higher-order chromatin topologies to safeguard genomic stability.

Identifiants

pubmed: 36854302
pii: S1097-2765(23)00083-7
doi: 10.1016/j.molcel.2023.02.004
pmc: PMC10467573
mid: NIHMS1915305
pii:
doi:

Substances chimiques

Chromatin 0
Telomere-Binding Proteins 0
Tumor Suppressor p53-Binding Protein 1 0
Cell Cycle Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1043-1060.e10

Subventions

Organisme : NCI NIH HHS
ID : P30 CA015083
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM065841
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Références

Cell Res. 2011 Jul;21(7):1028-38
pubmed: 21423270
Br J Cancer. 2020 Aug;123(4):633-643
pubmed: 32488136
Nat Struct Mol Biol. 2017 Feb;24(2):99-107
pubmed: 28067915
Biochem Biophys Res Commun. 2008 May 23;370(1):62-6
pubmed: 18355440
Methods. 2017 Feb 15;115:80-90
pubmed: 27713081
Nature. 2015 May 28;521(7553):541-544
pubmed: 25799992
Mol Cell. 2017 Oct 5;68(1):171-184.e6
pubmed: 28985503
Cell. 2015 Nov 5;163(4):880-93
pubmed: 26544937
Genes Dev. 2021 Oct 1;35(19-20):1356-1367
pubmed: 34503990
Nat Immunol. 2004 May;5(5):481-7
pubmed: 15077110
Nat Cell Biol. 2019 Oct;21(10):1273-1285
pubmed: 31548606
Biomark Res. 2015 May 01;3:9
pubmed: 26015868
Mol Cell. 2011 May 6;42(3):319-29
pubmed: 21549309
Mol Cell Biol. 2014 Apr;34(7):1349-62
pubmed: 24469404
Nat Struct Mol Biol. 2013 Mar;20(3):317-25
pubmed: 23377543
Cell. 2010 Jun 11;141(6):970-81
pubmed: 20550933
Trends Biochem Sci. 2020 Mar;45(3):177-179
pubmed: 31882194
Nat Rev Mol Cell Biol. 2020 Dec;21(12):765-781
pubmed: 33077885
Nature. 2018 Jul;559(7712):54-60
pubmed: 29925946
Redox Biol. 2014 Jan 09;2:457-65
pubmed: 24624335
Mol Cell. 2013 Mar 7;49(5):872-83
pubmed: 23333306
Clin Cancer Res. 2016 Aug 1;22(15):3764-73
pubmed: 26957554
Clin Cancer Res. 2017 Jan 15;23(2):523-535
pubmed: 27440269
Trends Immunol. 2002 Jan;23(1):31-9
pubmed: 11801452
J Cell Biol. 2006 Mar 13;172(6):823-34
pubmed: 16520385
Nat Cell Biol. 2020 Dec;22(12):1460-1470
pubmed: 33257806
Nat Commun. 2018 Mar 21;9(1):1165
pubmed: 29563550
Nature. 2018 Aug;560(7716):112-116
pubmed: 30022158
Nature. 2018 Aug;560(7716):122-127
pubmed: 30046110
Nat Microbiol. 2021 Feb;6(2):234-245
pubmed: 33432153
Cell. 2018 May 3;173(4):972-988.e23
pubmed: 29656893
Trends Genet. 2019 Sep;35(9):685-705
pubmed: 31371030
Cell. 2000 Sep 1;102(5):553-63
pubmed: 11007474
Gene. 2009 Nov 1;447(1):1-11
pubmed: 19619625
Genes Dev. 2017 Nov 15;31(22):2204-2221
pubmed: 29284710
Science. 2021 May 14;372(6543):
pubmed: 33986151
Nature. 2018 Jul;559(7712):61-66
pubmed: 29925947
Cell Rep. 2018 Apr 03;23(1):239-254.e6
pubmed: 29617664
Int Immunol. 2004 Oct;16(10):1535-48
pubmed: 15351786
Nat Cell Biol. 2022 Jan;24(1):51-61
pubmed: 35027730
Cell Biol Int. 2018 Jan;42(1):2-8
pubmed: 28460425
Cell Rep. 2017 Jan 31;18(5):1200-1214
pubmed: 28147275
Sci Adv. 2021 Jun 2;7(23):
pubmed: 34078602
IEEE Trans Image Process. 1998;7(1):27-41
pubmed: 18267377
Proc Natl Acad Sci U S A. 2019 Apr 9;116(15):7323-7332
pubmed: 30918123
Oncogene. 2017 Oct 26;36(43):6006-6019
pubmed: 28671669
Nat Struct Mol Biol. 2019 Dec;26(12):1087-1088
pubmed: 31792447
Mol Cell. 2020 Sep 3;79(5):824-835.e5
pubmed: 32649882
Pharmacol Ther. 2019 Sep;201:94-102
pubmed: 31128155
J Cell Biol. 2014 Jan 20;204(2):231-45
pubmed: 24446482
Nat Cell Biol. 2018 Aug;20(8):954-965
pubmed: 30022119
Nat Cell Biol. 2021 Aug;23(8):894-904
pubmed: 34354233
Nat Commun. 2017 Feb 08;8:14244
pubmed: 28176781
Mol Cell. 2018 Feb 1;69(3):371-384.e6
pubmed: 29395061
Mol Cell. 2013 Mar 7;49(5):858-71
pubmed: 23333305
Nature. 2008 Nov 27;456(7221):524-8
pubmed: 18931659
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2146-51
pubmed: 23345425
Nature. 2012 Nov 1;491(7422):125-8
pubmed: 23000900
Nat Rev Mol Cell Biol. 2014 Jan;15(1):7-18
pubmed: 24326623
Nature. 2018 Aug;560(7716):117-121
pubmed: 30022168
Science. 2013 Feb 8;339(6120):700-4
pubmed: 23306437
EMBO Rep. 2019 May;20(5):
pubmed: 30948458
Elife. 2021 May 04;10:
pubmed: 33942717
J Cell Sci. 2012 Aug 1;125(Pt 15):3529-34
pubmed: 22553214
EMBO Rep. 2016 Jan;17(1):94-109
pubmed: 26658330
Am J Cancer Res. 2020 Sep 01;10(9):2832-2850
pubmed: 33042620
Cell Rep. 2019 Aug 6;28(6):1389-1399.e6
pubmed: 31390554
Genes Dev. 2020 Jan 1;34(1-2):7-23
pubmed: 31896689
Nature. 2019 Oct;574(7779):571-574
pubmed: 31645724
Cell. 2010 Apr 16;141(2):243-54
pubmed: 20362325
Trends Biochem Sci. 2019 Jul;44(7):565-574
pubmed: 31072688
Nat Rev Mol Cell Biol. 2019 Nov;20(11):698-714
pubmed: 31263220

Auteurs

Jinzhou Huang (J)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Chenming Wu (C)

Key Laboratory of Arrhythmias of the Ministry of Education of China, Research Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China.

Jake A Kloeber (JA)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA; Medical Scientist Training Program, Mayo Clinic, Rochester, MN 55905, USA.

Huanyao Gao (H)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.

Ming Gao (M)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Qian Zhu (Q)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Yiming Chang (Y)

Jinzhou Medical University, Shanghai East Hospital, Shanghai 200120, China.

Fei Zhao (F)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Guijie Guo (G)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Kuntian Luo (K)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Haiming Dai (H)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Sijia Liu (S)

Department of Artificial Intelligence and Informatics, Mayo Clinic, Rochester, MN 55905, USA.

Qiru Huang (Q)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Wootae Kim (W)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Qin Zhou (Q)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Shouhai Zhu (S)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Zheming Wu (Z)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Xinyi Tu (X)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Ping Yin (P)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Min Deng (M)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Liewei Wang (L)

Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA.

Jian Yuan (J)

Key Laboratory of Arrhythmias of the Ministry of Education of China, Research Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China; Department of Biochemistry and Molecular Biology, Tongji University School of Medicine, Shanghai 200092, China. Electronic address: yuanjian229@hotmail.com.

Zhenkun Lou (Z)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA. Electronic address: lou.zhenkun@mayo.edu.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH